how do you know what crypto to buy Knowledge

On the 12th, the South Korean National Assembly voted to impeach the Minister of Justice Park Hyung-jae and the Director of the Police Department Zhao Zhihao.Hebang Bio established a mining engineering company in Leshan, Sichuan. The enterprise search APP shows that Leshan Hebang Mining Engineering Co., Ltd. was established recently, with Fei Wang as the legal representative and a registered capital of 10 million yuan. Its business scope includes: mineral resources reserve evaluation service; Mineral resources reserve estimation and report preparation services; Geological disaster management services, etc. Enterprise investigation shows that the company is wholly owned by Hebang Bio.Enterprise IT Expenditure Survey: Google Cloud is expected to be the first choice for 50% of the respondents. Tae Kim, a science and technology columnist, wrote that according to a recent survey, Google Cloud has risen rapidly in the enterprise AI expenditure competition and may become the winner. According to the 2025 CIO survey released by Piper Sandler, 81 CIOs were asked about their budget priorities in different suppliers and technical fields. According to the survey, 87% of CIOs surveyed expect to increase the IT budget in 2025, which is the highest proportion of the survey since 2020. In this survey, the status of Google Cloud has risen significantly, surpassing Microsoft and OpenAI to become the "most strategic" AI supplier, with a support rate of 27%, a significant increase from 15% six months ago. Relatively speaking, Microsoft's support rate dropped from 33% to 24%. When asked which cloud company they plan to use to test or implement AI projects next year, 50% of the respondents chose Google Cloud, making it the top AI infrastructure provider. In addition, Harsh Kumar, a Piper semiconductor analyst, pointed out that these results are also beneficial to Invista, because all cloud companies are the main buyers of AI chips in NVIDIA. Kumar estimates that the entire AI chip market will have more than $500 billion in business opportunities by 2028.

CEO of Bank of America: The sales and trading business is expected to reach a new high in the fourth quarter, and the investment banking business income will jump. On December 11th, the CEO of Bank of America Brian moynihan said that with the "continuous growth" of transactions, the bank's investment banking business income in the fourth quarter may exceed US$ 1.4 billion, with a year-on-year increase of at least 25%. Moynihan also said that the sales and trading business in the fourth quarter should record a year-on-year growth again, achieving a medium-to-high single-digit growth. The bank also expects that the net interest income will continue to grow, which is expected to achieve the guiding target of $14.3 billion given earlier this year.The Nikkei 225 index just broke through the 39,900.00 mark, and the latest report was 39,899.07, up 1.34% in the day.During the "slimming" of the brokerage business department, more than 100 companies were cancelled during the year, and the competition turned to differentiated services. The brokerage business of brokerage companies is welcoming a new round of changes. In the past few days, a number of brokers have announced the cancellation of their relevant business departments. According to the reporter's incomplete statistics, in the past two weeks, many brokers such as Nanjing Securities, Guosen Securities and Pacific Securities announced that they would "streamline" their business departments. Looking at it for a long time, more than 35 brokers have issued announcements during the year, "downsizing" hundreds of business departments. Insiders pointed out that the traditional offline outlet business development model has increasingly shown drawbacks and high cost pressure; At the same time, more and more customers rely on online transactions and mobile terminal transactions, so it is imperative to "streamline" the business department to reduce costs and increase efficiency. Future competition depends more on differentiated financial management and trading services. (Shell Finance)

In the latest centralized purchase of sitagliptin tablets, the price dropped to less than 20 cents per tablet, with a drop of over 90%. The reporter learned at the scene of the tenth batch of drug centralized purchase that more than 30 companies bid for sitagliptin, which is known as the largest variety in this centralized purchase, including Huahai Pharmaceutical, Kelun Pharmaceutical, Zhengda Tianqing, tonghua dongbao, Zhejiang Pharmaceutical, Jiudian Pharmaceutical, Shiyao Ouyi, Chenxin Pharmaceutical and many other companies. Judging from the bidding results, the lowest bid price among enterprises has dropped below 0.2 yuan per piece, which is more than 90% lower than the limit price. Statistics show that in 2023, the sales of this product in the terminals of public medical institutions in China exceeded 2 billion yuan, and the sales of Merck, the original research manufacturer, accounted for more than 90%, so there is a large room for the replacement of generic drugs. The quotation of Meradong in this collection is about 7.37 yuan per piece. (science and technology innovation board Daily)Zhang Feng, president of Duodianzhi: The retail digital intelligence infrastructure company has developed a number of AI products. On December 12, at the annual partner conference of Duodianzhi in 2024, Zhang Feng, president of Duodianzhi, said that Duodianzhi would always insist on using technology to promote retail development and insist on retail digital intelligence infrastructure. At present, AI technology is booming, and AI will also accelerate the iterative speed of multi-point intelligent systems. In the past year, Duodian has developed a variety of AI products, such as clearing, inspection, etc., and actively practiced and quickly landed, all of which are preparing for the full arrival of the AI ​ ​ era.Guangxi: In November, 23,774 cases of legal infectious diseases were reported and 320 people died. The Health and Health Commission of Guangxi Zhuang Autonomous Region announced the epidemic situation of legal infectious diseases in Guangxi in November 2024. No cases of Class A infectious diseases were reported. 14,775 cases of Class B infectious diseases were reported, with 320 deaths. The reported diseases include AIDS, viral hepatitis, rabies, dengue fever, dysentery, tuberculosis, typhoid plus paratyphoid, whooping cough, scarlet fever, brucellosis, gonorrhea, syphilis, leptospirosis, malaria, novel coronavirus infection and monkeypox. The top five reported cases were viral hepatitis, tuberculosis, syphilis, AIDS and gonorrhea, accounting for 94.34% in total. 8999 cases of Class C infectious diseases were reported, with no death. The reported diseases include influenza, mumps, rubella, acute hemorrhagic conjunctivitis, leprosy, typhus, other infectious diarrhea and hand, foot and mouth disease. The top three reported cases were other infectious diarrhea, hand-foot-mouth disease and influenza, accounting for 91.43% in total.